Mark Pass, SHRM-SCP, PRC, CIR

If that hire in the Regulatory, Clinical, Quality Assurance or Program Management function is giving you trouble call Gabrielle Sacco on the HireMinds team for back-up. She's regularly engaging with top active and passive talents to find them relevant opportunities with the best biotechs across the U.S. #regulatoryaffiars #clinicaloperations #qualityassurance

2

🌟 Exciting Partnership announcement! 🌟 Stilla Technologies, a pioneer in digital PCR systems, has forged a strategic distribution partnership with Avantor to bring their innovative dPCR products to the US market! 🇺🇸🔬 Under this new agreement, Avantor's life science specialists will make Stilla's advanced dPCR solutions available to researchers and clinicians across the country. 🧬💼 "With Avantor's backing, we are well positioned to achieve our biopharma, applied testing, and academia objectives while enhancing our applications to better serve our customers," shared Kerri McWeeny, Stilla's GM for North America. Highlights: 🔹 Stilla launched the seven-color Nio+ dPCR instrument last year. 🔹 Secured a $26.5M Series C financing round for scaling and commercialization. 🔹 Avantor's history of strategic acquisitions and partnerships, including Puritan Medical Products , VWR, part of Avantor, and Oxford Nanopore Technologies. This partnership is set to propel advancements in biopharma, applied testing, and academic research, driving innovation and excellence in the life sciences sector. 🌐🚀 #DigitalPCR #Biotech #LifeSciences #Research #Innovation #Partnership #StillaTechnologies #Avantor #Biopharma #ScientificResearch #HealthcareInnovation 🌟🔬💼

4

1 Comment

During AMCP, Cencora team members showcased research posters covering various managed care topics. We discussed their impactful work and its potential implications. Kyle A. Noonan, PharmD, MS, Manager of Value Access and Strategy, provides insights into his silver medal award-winning poster titled “Payer perspectives of cell therapy and gene therapy treatment paradigms for an Inherited retinal disorder,” discussing payer preferences for gene therapy and uncertainties surrounding cell therapies not yet on the market. Explore Kyle's perspectives on treatment paradigms: https://ow.ly/c1xK50SpveY

25

With all of the recent biopharma layoffs, many industry professionals are looking to land their next gig. But if its been a while since your last job interview, you’re probably worried about being rusty. Thankfully, a little preparation can go a long way. One area that’s often overlooked? The opportunity at the end of a job interview to ask questions. A recent article from Harvard Business Review provides some excellent question recommendations so you can learn more about your potential boss and the company’s culture. Check it out! Source: https://hubs.li/Q02mXpk50 #layoffs #careeradvancement #jobinterviews #biopharma #professionaldevelopment #careerpaths #aceyourinterview

2

LAST CHANCE to submit your topics and presentations for the 2024 ASAP BioPharma Conference! The conference will be held in Boston from November 4-6, 2024. We need your expertise and thought-leadership to ensure the most valuable and current topics regarding partnering, collaboration, and alliance management in the biopharma and life sciences industries are addressed. Don't miss this opportunity to contribute your knowledge! Submit your topics before the deadline on Friday, May 3, 2024 at https://lnkd.in/ehXhGm7U. #alliancemanagement #alliances #strategicalliances #alliancemanagers #collaboration #strategicpartnerships #pharmaceutical #pharmaceuticalindustry #biopharma #biotech #biotechnology #biotechindustry

4

Galvanize Therapeutics, Inc. 𝐞𝐧𝐝𝐨𝐬𝐜𝐨𝐩𝐢𝐜, 𝐩𝐮𝐥𝐬𝐞𝐝-𝐟𝐢𝐞𝐥𝐝 𝐧𝐞𝐞𝐝𝐥𝐞 𝐬𝐜𝐨𝐫𝐞𝐬 𝐅𝐃𝐀 𝐜𝐥𝐞𝐚𝐫𝐚𝐧𝐜𝐞 ✅ Pulsed field ablation ⚡(#PFA) has been making waves in #cardiac 🫀 procedures in the past few months as a treatment for #atrialfibrillation (#AF) and irregular #heartrhythm with fewer side effects. Now, Galvanize Therapeutics, Inc. is jumping in with its system that broadens the use of the tech to patients with #cancer... The company has received #FDA #510k clearance for its #INUMI Flex #endoscopic needle #ablation system, a part of its #Aliya #pulsedfieldablation energy portfolio, for use against soft-tissue lesions including nodules that can harbor #lungcancer tumor cells. 🫁 Compared to traditional #surgicalablation approaches that deliver heat or cold energy to a broader area, #PFA aims to be more selective by using tuned electricity to break down the membranes of troublesome cells. The company received $100M in #SeriesB funding which including investment from Intuitive Ventures.💸 Aliya is also being explored for #livercancer, #kidneycancer and #breastcancer. Jonathan Waldstreicher, MD CEO said: 🗣 “As physicians increasingly shift from #percutaneous to #endoscopic access of target lesions, our team developed INUMI Flex to meet their needs. Having demonstrated the effects of Aliya beyond #focalablation in early studies, we continue to invest in understanding the full potential of biologic activation and its unique immune response in clinical trials.” Congratulations to the Galvanize Therapeutics, Inc. team! 👏👏 For more information on #PFA technology for treating #CardiacArrhythmias and the players in this critical market, check out my recent post in the link below: ⤵ https://shorturl.at/2TTSy #medtech #medicaldevice #oncology #lungcancer #pfa #pulsedfieldablation #endoscopy #minimallyinvasive #cancertreatment #executivesearch #recruitment #healthcare #innovation #cardiology

23

🔬 At Lampgen Clinical Research, we specialize in staffing expert oncology CRAs to ensure cancer clinical trials are monitored with ICH/GCP and industry-standard expertise. As the preferred staffing firm for sponsors and CROs in oncology, we pride ourselves on our commitment to excellence in clinical research. 🌟 We're thrilled to see Bristol Myers Squibb's Krazati gain accelerated approval for colorectal cancer patients. This breakthrough KRAS inhibitor, now approved for use with Eli Lilly’s Erbitux (cetuximab), offers new hope for patients with KRAS G12C mutations—a group traditionally facing poor prognosis and limited treatment options. KRAS mutations have long been a challenging target in cancer treatment. Krazati’s ability to inhibit the KRAS protein represents a significant advancement, providing a new therapeutic strategy for controlling tumor growth. This approval not only builds on Krazati's previous success in non-small cell lung cancer but also marks it as the first KRAS-targeting drug for colorectal cancer, a major step forward in oncology. This milestone underscores the evolving landscape of cancer treatment and the importance of innovative therapies in improving patient outcomes. At Lampgen, we're dedicated to supporting these advancements by providing top-tier clinical research staffing solutions. #OncologyResearch #ClinicalTrials #CancerTreatment #KRASInhibitors #ColorectalCancer #ClinicalResearch #CancerCare #LampgenClinicalResearch #MedicalInnovation #HealthcareAdvancement #ResearchStaffing #OncologyCRAs #CancerBreakthroughs #Pharmaceuticals #DrugDevelopment #PatientCare #BristolMyersSquibb #NewApprovals 🔗 https://lnkd.in/eaGBVjqD

2

Join our upcoming webinar next week with California Life Sciences (CLS), featuring Avance Clinical’s scientific and regulatory affairs experts, showcasing the clinical trials landscape and regulatory frameworks that are essential for accelerating drug development programs towards global approval. Our experts Alex Kavros, PhD, Kevin Leach, Ph.D, DABT and Jorgen Mould will delve into the intricacies of the drug development process, offering deep dives into the critical phases of bringing a therapeutic concept to the clinic. From the foundational steps in preclinical research to the pivotal milestones of Phase I and II clinical trials, attendees will gain invaluable insights. Register here: https://bit.ly/49VgOiB #AvanceClinical #CLS #CaliforniaLifeSciences #earlystagebiotech #drugdevelopment #Australia #UnitedStates #CRO #scientificaffairs #regulatoryaffairs #webinar #experts #preclinical #clinicaltrials

34

Are your current methods for analyzing immune repertoire data holding back your antibody discovery efforts? In this case study, we empowered a client's antibody discovery by building a robust, high-throughput pipeline for immune repertoire data analysis: https://hubs.la/Q02zgwz20 This pipeline efficiently processed hundreds of millions of reads within their cloud environment, allowing for: • Scalability for diverse data sets • Customized processing options • Clear visualizations for comprehensive analysis Witness how our innovative methodologies have dramatically accelerated data analysis, leading to the discovery of groundbreaking antibodies #Excelra #antibodydiscovery #dataanalysis #datavisualization #casestudy #drugdiscovery Bindu Ajithkumar Puneet Saxena Chandra Sekhar Pedamallu Uzma Saeed Jan Ghyssaert Martijn Heeneman

24

Recruiter tip: For biotech job applications, do not put graphics in your resume. We sometimes see a resume with graphs or colorful elements to describe the candidate's experience. While the candidate understands what they meant, the recruiter has no clue! What exactly is 4 out of 5 stars for cell culture experience? It leads the recruiter or manager to question a resume more than to consider it. Keep your resume format simple and clean. Boring and black-and-white is best!

20

🌟 Exciting News from Diasorin! 🌟 DiaSorin has just received FDA 510(k) clearance for its updated NxTag Respiratory Pathogen Panel v2, now including SARS-CoV-2 detection! 🎉 This advanced multiplex PCR assay can detect 19 viral and 2 bacterial targets, offering comprehensive insights into respiratory infections. With improvements in test accuracy and ease of use, this panel ensures top-notch performance on the high-throughput Luminex Magpix instrument, which can process 96 specimens per run. 💪🔬 Thanks to support from the U.S. Department of Health and Human Services (HHS) and Human Services' BARDA, DiaSorin has enhanced its capabilities to meet the ongoing challenges of respiratory pathogens. 🤝 Key Highlights: ✅ Includes SARS-CoV-2 along with other coronaviruses, flu A/B, RSV, and more. ✅ Enhanced accuracy and user-friendly design. ✅ Ready-to-use lyophilized reagent wells for convenience. This advancement represents a significant step forward in diagnostic precision and support for public health. 🌍💙 #DiaSorin #FDAApproval #PCR #Diagnostics #SARSCoV2 #HealthcareInnovation #RespiratoryHealth #PublicHealth #BARDA #MedicalResearch #LaboratoryScience #HighThroughputTesting

2

2 Comments

🧬 Exciting Product Launches in Genomics! 🧬 New products from some of the leading names in genomics and molecular biology, including Integrated DNA Technologies, GT Molecular, Illumina, QIAGEN, Bio-Rad Laboratories, and SPT Labtech! 🎉🔬 -IDT (Integrated DNA Technologies): Introducing advanced oligonucleotide synthesis products to enhance genetic research and diagnostics. 🧬 -GT Molecular: Launching innovative molecular diagnostic tools for detecting and quantifying pathogens with unprecedented accuracy. 🦠 -Illumina: Unveiling the latest in sequencing technology, aimed at increasing throughput and reducing costs, thereby making genomics more accessible. 🧬📈 -Qiagen: Offering new solutions in sample preparation and next-generation sequencing (NGS) to streamline workflows and improve data quality. 🔬 -Bio-Rad: Expanding their portfolio with cutting-edge PCR and qPCR products designed for precise and reliable genetic analysis. 🧪 -SPT Labtech: Launching innovative liquid handling and automation solutions to optimise lab efficiency and reproducibility. 🤖 These groundbreaking products are poised to drive significant advancements in genomic research, clinical diagnostics, and personalised medicine. Looking forward to seeing the transformative impact these new tools will have on the scientific and healthcare communities! #Genomics #Biotech #NewProducts #HealthcareInnovation #IDT #GTMolecular #Illumina #Qiagen #BioRad #SPTLabtech #ScientificResearch #InnovationInScience #MolecularBiology #MedicalAdvancements #NGS #PCR #LabAutomation

9

1 Comment

Yesterday, Gordon Haner, MBA, LATG, ILAM was onsite at EMD Serono, Inc. for a Biotech Vendor Services, Inc. vendor show! Thank you to all those who came to talk to Gordon about GemPharmatech's mouse models and preclinical services. If you are in the #bostonbiotech community make sure to reach our to Gordon if you do preclinical research with mouse models. Also a thank you to Matthew Potter and BVS! See you again soon, new EMD and MilliporeSigma friends! #preclinicalresearch #oncology #autoimmune #vendorshow #bvs #bvsvendorshow

29